363 results
NT 10-K
ELOX
Eloxx Pharmaceuticals, Inc.
1 Apr 24
Notice of late annual filing
4:02pm
the financial resources necessary to engage its independent public accounting firm to perform an audit of the Company’s financial statements for the year … the audit of the 2023 Financial Statements will be completed and if and when it will file the Form 10-K.
PART IV — OTHER INFORMATION
Name and telephone
8-K
EX-1.1
yfccd
24 May 23
Entry into a Material Definitive Agreement
8:07am